Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Enrolling by invitation × Dexamethasone × Plasma cell × Clear all

Phase

Status

Completed 326 Active not recruiting 117 Terminated 92 Recruiting 79 Unknown 54 Withdrawn 37 Not yet recruiting 18 Suspended 2 No longer available 2 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Other hematologic neoplasm 1 Gastrointestinal 1

Conditions

Multiple Myeloma 1

Interventions

Lenalidomide 1 Dexamethasone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07210047 2025-10-07

Study of HuL001 in Relapsed/Refractory Multiple Myeloma Patients

HuniLife Biotechnology, Inc.

Phase 1/2 Enrolling by invitation

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡